Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide. [electronic resource]
Producer: 20101207Description: 359-66 p. digitalISSN:- 1365-2796
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Aryl Hydrocarbon Hydroxylases -- antagonists & inhibitors
- Cytochrome P-450 CYP2C9
- Diabetes Mellitus, Type 2 -- drug therapy
- Drug Interactions
- Female
- Glipizide -- therapeutic use
- Glyburide -- therapeutic use
- Hospitalization
- Humans
- Hypoglycemic Agents -- therapeutic use
- Male
- Middle Aged
- Sulfonylurea Compounds -- therapeutic use
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.